Market Share Analysis for Sodium Reduction Ingredients, Global Industry Trends, and Growth Prediction to 2032

A large market value of USD 9,665.4 Mn is anticipated for the worldwide sodium reduction ingredients market during the projected period of 2022 to 2032, with a CAGR of 5.8%. In 2032, it is anticipated that the market would be worth USD 5,500 Mn. Key Takeaway: Mineral salts are likely to be a fast-growing market …

Citrus Flavors Market Research Report 2032 – Market Size, Industry Outlook, Market Forecast Report

According to Future Market Insights’ research, the Citrus Flavors Market will grow globally at a CAGR of 4.9% over the forecast period. The market is expected to be worth US$19.4 billion by 2032. The clean label movement is broadening its scope to include products that can be linked to health benefits. The term “clean label” …

Analysis of Beta-glucan Market For 2032: Positioning, Future Prospects, and Sales Forecast

The beta-glucan market is predicted to be worth USD 1,200 million in 2022 and USD 2,108.8 million in 2032, with a CAGR (compound annual growth rate) of 5.8% over the course of the assessment period. As demand has switched from commercial food products to nutritious food, food supplements, and superfoods, customers have become more aware of …

Adrenogenital Syndrome Treatment Market is expected to garner a value of US$ 22.08 Billion

The global adrenogenital syndrome treatment market is expected to reach $12.81 billion in 2023, with a 5.6% CAGR from 2023 to 2033. Growth is expected to be driven by natural treatments, minimally invasive surgeries, and new therapies. In Austria, newborn screening programmes have been established to detect severe forms of AGS so that affected children …

Abetalipoproteinemia Management Market is projected to reach US$ 341 million by 2033

The global abetalipoproteinemia management market is expected to surpass a valuation of US$ 147 million in 2023 and reach US$ 341 million by 2033, growing at an 8.78% CAGR. During the forecast period, the market for Abetalipoproteinemia will be driven by the rising prevalence of imaging studies such as hepatic scans or ultrasonography to assess …

Alcohol Use Disorder Treatment Market to expand at a 6.4% value CAGR by 2033

The global alcohol use disorder treatment market was worth US$ 700 million in 2023 and is expected to be worth US$ 1,300 million by 2033, growing at a CAGR of 6.4% between 2023 and 2033. The increased prevalence of alcohol abuse and binge drinking is expected to fuel the industry. This disease knows no bounds …

Biosensors Market is projected to witness a CAGR of 9.5% from 2023 to 2033

According to Future Market Insights’ newly released Biosensors Market analysis report, the global market size of the Biosensors Market in 2022 will be US$ 24.5 Billion. The projected market growth is expected to be significantly higher than the historical growth, with a CAGR of 9.5% from 2023 to 2033. Medical biosensors are expected to be …

Systemic Lupus Erythematous SLE Drugs Market is likely to be US$ 329.18 Billion by 2032 | FMI Analyst

The Systemic Lupus Erythematosus (SLE) Drugs Market is expected to grow at a 5% CAGR during the forecast period, from US$ 183.3 billion in 2020 to US$ 329.18 billion by 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Systemic …

Spectrophotometers Market is anticipated to register a CAGR of 4.2% by 2032 | Says FMI Analyst

[Report of 250 Pages] The Spectrophotometers Market is expected to grow at a CAGR of 4.2% between 2022 and 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Spectrophotometers market. FMI offers insights into the market data on over 5000+ …

Ultrasound-Guided Breast Biopsy Market is expected to reach US$ 1,090 Million in 2032 | FMI Analyst

The Global Ultrasound-Guided Breast Biopsy Market is expected to reach US$ 1,090 Million in 2032, growing at an 8% CAGR during the forecast period. The ultrasound-guided biopsy market is currently valued at US$ 720 Million in 2022. Rising incidence of breast cancer cases and increased awareness about early detection of breast cancer will drive market …